Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib.
Vigoda M, Mathieson C, Evans N, Hale C, Jennings J, Lucero O, Jeng S, Bottomly D, Clayburgh D, Andersen P, Li R, Petrisor D, Tyner JW, McWeeney S, Kulesz-Martin M. Vigoda M, et al. Among authors: kulesz martin m. Cancer Biol Ther. 2022 Dec 31;23(1):310-318. doi: 10.1080/15384047.2022.2055420. Cancer Biol Ther. 2022. PMID: 35343367 Free PMC article.
Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models.
Ouyang X, Barling A, Lesch A, Tyner JW, Choonoo G, Zheng C, Jeng S, West TM, Clayburgh D, Courtneidge SA, McWeeney SK, Kulesz-Martin M. Ouyang X, et al. Among authors: kulesz martin m. Cancer Biol Ther. 2018;19(10):921-933. doi: 10.1080/15384047.2018.1451285. Epub 2018 Aug 17. Cancer Biol Ther. 2018. PMID: 29856687 Free PMC article.
Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma.
Choonoo G, Blucher AS, Higgins S, Boardman M, Jeng S, Zheng C, Jacobs J, Anderson A, Chamberlin S, Evans N, Vigoda M, Cordier B, Tyner JW, Kulesz-Martin M, McWeeney SK, Laderas T. Choonoo G, et al. Among authors: kulesz martin m. PLoS One. 2019 Oct 9;14(10):e0223639. doi: 10.1371/journal.pone.0223639. eCollection 2019. PLoS One. 2019. PMID: 31596908 Free PMC article.
Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma.
Anderson AN, McClanahan D, Jacobs J, Jeng S, Vigoda M, Blucher AS, Zheng C, Yoo YJ, Hale C, Ouyang X, Clayburgh D, Andersen P, Tyner JW, Bar A, Lucero OM, Leitenberger JJ, McWeeney SK, Kulesz-Martin M. Anderson AN, et al. Among authors: kulesz martin m. Cold Spring Harb Mol Case Stud. 2020 Aug 25;6(4):a005439. doi: 10.1101/mcs.a005439. Print 2020 Aug. Cold Spring Harb Mol Case Stud. 2020. PMID: 32843430 Free PMC article.
Evidence-Based Precision Oncology with the Cancer Targetome.
Blucher AS, Choonoo G, Kulesz-Martin M, Wu G, McWeeney SK. Blucher AS, et al. Trends Pharmacol Sci. 2017 Dec;38(12):1085-1099. doi: 10.1016/j.tips.2017.08.006. Epub 2017 Sep 27. Trends Pharmacol Sci. 2017. PMID: 28964549 Free PMC article. Review.
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis.
Tsujikawa T, Kumar S, Borkar RN, Azimi V, Thibault G, Chang YH, Balter A, Kawashima R, Choe G, Sauer D, El Rassi E, Clayburgh DR, Kulesz-Martin MF, Lutz ER, Zheng L, Jaffee EM, Leyshock P, Margolin AA, Mori M, Gray JW, Flint PW, Coussens LM. Tsujikawa T, et al. Cell Rep. 2017 Apr 4;19(1):203-217. doi: 10.1016/j.celrep.2017.03.037. Cell Rep. 2017. PMID: 28380359 Free PMC article.
102 results